 Home > Active Ingredient News > Antitumor Therapy > JCEM: The relationship between oral contraceptives and menopausal hormone therapy and the risk of pituitary adenoma

JCEM: The relationship between oral contraceptives and menopausal hormone therapy and the risk of pituitary adenoma

 Last Update: 2021-12-25
 Source: Internet
 Author: User

Tags

journal infectious diseases

journal computational chemistry

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Currently, there are no prospective epidemiological studies evaluating the association between the use of oral contraceptives (OC) or menopausal hormone therapy (MHT) and the risk of female pituitary adenomas

Recently, a research article was published in the Journal of Clinical Endocrinology & Metabolism, an authoritative journal in the field of endocrine and metabolic diseases.

During the annual follow-up of 6,668,019 people, 331 participants reported pituitary adenomas

When stratified by BMI, the results of the hysteresis analysis are similar

It can be seen that in two independent data sets, compared with never use, current and past use of MHT and longer duration of use of MHT are positively correlated with a higher risk of pituitary adenoma

Compared with never use, current and past use of MHT and longer duration of use of MHT are positively correlated with a higher risk of pituitary adenoma

Original source:

David J Cote.

Oral contraceptive and menopausal hormone therapy use and risk of pituitary adenoma: cohort and case-control analyses

in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.